4//SEC Filing
McCulloch Kevin 4
Accession 0001867096-25-000060
CIK 0001867096other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 4:20 PM ET
Size
6.7 KB
Accession
0001867096-25-000060
Insider Transaction Report
Form 4
McCulloch Kevin
See Remarks
Transactions
- Tax Payment
Common Stock
2025-04-02$5.15/sh−733$3,775→ 1,683,585 total
Holdings
- 25,000(indirect: By Spouse)
Common Stock
- 2,000(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of April 2, 2025.
- [F2]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Documents
Issuer
Xeris Biopharma Holdings, Inc.
CIK 0001867096
Entity typeother
Related Parties
1- filerCIK 0002031695
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 4:20 PM ET
- Size
- 6.7 KB